News & Perspective

Dec 19, 2002

Dec 19, 2002

VaxGen to seek US licensing for attenuated smallpox vaccine

(CIDRAP News) – VaxGen Inc., a California biotechnology company, announced plans this week to seek US licensing for an attenuated smallpox vaccine that is considered safer than existing vaccines but was developed too recently to be proved effective against the disease.